Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Xenetic Biosciences Inc market cap is $3.89M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Xenetic Biosciences Inc 52 week high is $4.94 as of November 17, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Xenetic Biosciences Inc 52 week low is $1.43 as of November 17, 2026.
Xenetic Biosciences Inc stock price today is $1.49.
Xenetic Biosciences Inc stock price yesterday was $1.66.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Xenetic Biosciences Inc's P/E ratio is -0.94.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Xenetic Biosciences Inc P/B ratio is 0.791.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Xenetic Biosciences Inc 50-day moving average is $2.35.